Loading viewer...
investor_presentation
Format: PDF investor_presentation
Presentation outlining Grifols' acquisition of Biotest AG, a bioscience company specializing in plasma-derived therapies and transfusion medicine diagnostics. The investment highlights Biotest's four core divisions: Bioscience (78% of revenues), Diagnostic (15%), Hospital (3%), and Bio Supplies (4%), positioning Grifols as a global leader in essential plasma-based healthcare solutions.
investor_presentation
22 Pages
Simulations Plus